e-ISSN: Pending
Negative / Null Result ReportOpen accessInfectious and parasitic diseases

Completion of tuberculosis preventive treatment with 300 mg vs. 100 mg isoniazid tablets: a pragmatic randomized clinical trial

João Paulo Cola; Thiago Nascimento do Prado; Bárbara Manuella Cardoso Sodré Alves; Carolina Maia Martins Sales; Bárbara Juliana Pinheiro Borges; Keila Cristina Mascarello; Anne Caroline Barbosa Cerqueira Vieira; Silvia das Dores Rissino · 2025 · BMC Infectious Diseases

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Abstract Background Monotherapy with the drug isoniazid (INH) was for a long time the main therapeutic regimen used for tuberculosis preventive treatment (TPT). Research is progressing into the use of new therapeutic regimens that provide more complete TPT. The objective was to analyze the completion and safety of TPT with the drug INH in the form of 300 mg tablets. Methods Pragmatic, randomized, non-blinded, multicenter clinical trial conducted in Brazil from January 2019 to December 2022. Subjects over the age of 18 years with an indication for TPT was included and those whose index case of

Abstract by João Paulo Cola; Thiago Nascimento do Prado; Bárbara Manuella Cardoso Sodré Alves; Carolina Maia Martins Sales; Bárbara Juliana Pinheiro Borges; Keila Cristina Mascarello; Anne Caroline Barbosa Cerqueira Vieira; Silvia das Dores Rissino, BMC Infectious Diseases (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1186/s12879-025-10678-z